Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension
- PMID: 19897557
- DOI: 10.1183/09031936.00070209
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension
Abstract
Acute right ventricular failure in the setting of pulmonary arterial hypertension (PAH) often requires hospitalisation in intensive care units (ICU) to manage the subsequent low cardiac output and its consequences. There are very few data on these acute events. We recorded demographic, clinical and biological data and therapy in consecutive patients suffering from acute right heart failure requiring catecholamine treatment in the ICU of the French referral centre for pulmonary hypertension. These variables were analysed according to the survival status in ICU. 46 patients were included, the mean age was 50.3 yrs. ICU mortality was 41%. We found no difference in terms of demographics, clinical data, last haemodynamic measurements at admission. Systemic arterial pressure was significantly lower in the subgroup of patients whose clinical course was fatal. Plasma brain natriuretic peptide (BNP), C-reactive protein (CRP), serum sodium and creatinine at admission correlated with survival. Demonstration of an infection during the ICU stay was associated with a worse prognosis. These preliminary results underline the importance of some simple clinical and biological parameters in the prognostic evaluation of acute heart failure in the setting of PAH. Whether these parameters can guide therapy needs to be further investigated.
Comment in
-
Defend the right ventricle with what you know.Eur Respir J. 2010 Jun;35(6):1203-5. doi: 10.1183/09031936.00011110. Eur Respir J. 2010. PMID: 20513908 No abstract available.
Similar articles
-
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension.Eur Respir J. 2011 Aug;38(2):359-67. doi: 10.1183/09031936.00148310. Epub 2011 Feb 10. Eur Respir J. 2011. PMID: 21310884
-
Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.Am Heart J. 2003 Feb;145(2):310-6. doi: 10.1067/mhj.2003.146. Am Heart J. 2003. PMID: 12595849
-
Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.Crit Care Med. 2006 Aug;34(8):2140-4. doi: 10.1097/01.CCM.0000229144.97624.90. Crit Care Med. 2006. PMID: 16763507
-
Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.Crit Care Med. 2008 Jan;36(1 Suppl):S17-27. doi: 10.1097/01.CCM.0000296266.74913.85. Crit Care Med. 2008. PMID: 18158473 Review.
-
Acute decompensated pulmonary hypertension outcomes in pulmonary arterial hypertension patients: systematic review and meta-analysis of proportions.Heart Lung. 2025 Mar-Apr;70:57-64. doi: 10.1016/j.hrtlng.2024.11.009. Epub 2024 Nov 23. Heart Lung. 2025. PMID: 39579648
Cited by
-
The COVID-19 pandemic and pulmonary arterial hypertension in Italy: adaptation, outcomes and valuable lessons learned.Eur Respir J. 2022 Oct 6;60(4):2200796. doi: 10.1183/13993003.00796-2022. Print 2022 Oct. Eur Respir J. 2022. PMID: 36202406 Free PMC article.
-
[Treatment of acute and chronic right ventricular failure].Med Klin Intensivmed Notfmed. 2016 Jun;111(5):463-80. doi: 10.1007/s00063-016-0181-9. Epub 2016 May 30. Med Klin Intensivmed Notfmed. 2016. PMID: 27241776 Review. German.
-
Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.Cell Mol Life Sci. 2012 Sep;69(17):2805-31. doi: 10.1007/s00018-012-0950-4. Epub 2012 Mar 25. Cell Mol Life Sci. 2012. PMID: 22446747 Free PMC article. Review.
-
Pulmonary artery acceleration time accuracy for systolic pulmonary artery pressure estimation in critically ill patients.Ultrasound J. 2022 Jun 20;14(1):26. doi: 10.1186/s13089-022-00276-4. Ultrasound J. 2022. PMID: 35723841 Free PMC article.
-
Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers.Front Physiol. 2018 May 23;9:609. doi: 10.3389/fphys.2018.00609. eCollection 2018. Front Physiol. 2018. PMID: 29875701 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous